Lisa R. Diller, MD

Chief Medical Officer, Dana-Farber/Boston Children's Cancer and Blood Disorders Center
Clinical Director, Pediatric Oncology
Medical Director, Clinical Cancer and Blood Disorders Service Line
Medical Director, David B. Perini, Jr. Quality of Life Clinic
Institute Physician
Professor of Pediatrics, Harvard Medical School
Office Phone: 617-632-5642
Appointment Phone: 888-733-4662 (new); 617-632-3270 (established)
Fax: 617-582-9049
Preferred Contact Method: office phone


Treatment Centers
Pediatric Hematology/Oncology
Clinical Interests
Late effects of pediatric cancer, Retinoblastoma, Solid tumors, Wilms tumor, Neuroblastoma, Cancer predisposition, Melanoma, Global health


Dana-Farber Cancer Institute
450 Brookline Avenue
Boston, MA  02215


Board Certifications
Pediatric Hematology/Oncology
Boston Children's Hospital/Dana-Farber Cancer Institute, Pediatric Hematology/Oncology, 07/88 to 06/91
Boston Children's Hospital, Pediatrics, 07/86 to 06/88
Children's Hospital Boston, 07/85 to 06/86
Medical School
University of California, San Diego School of Medicine, 1985

Dr. Lisa Diller is the Chief Medical Officer, Dana-Farber/Boston Children's Cancer and Blood Disorders Center. As a pediatric oncologist and the Clinical Director of Pediatric Oncology, she leads the joint clinical Pediatric Oncology Program at the Dana-Farber Cancer Institute and Boston Children's Hospital. She is also the Director of the Perini Family Survivors Center and the David B. Perini, Jr. Quality of Life Clinic for Cancer Survivors at Dana-Farber. She is a Professor of Pediatrics at Harvard Medical School. Dr. Diller received a bachelors degree from Harvard University, and earned her medical degree from the University of California at San Diego. She was a resident at Boston Children's Hospital and did her subspecialty training at Boston Children's Hospital/Dana-Farber Institute where she has been on the faculty for more than 20 years. Dr. Diller's research focuses on the late effects of treatment for childhood cancer and genetic cancer predisposition syndromes in childhood. In addition, she investigates novel treatments for pediatric solid tumors, particularly tumors that occur in infants and toddlers.

Video: Meet Lisa R. Diller

Lisa Diller, MD, describes her clinical interests in neuroblastoma and childhood cancer survivors.

Lisa Diller, MD, discusses some of the most common side effects of childhood cancer, specifically those that occur later in the patient's life.

Appointments & Second Opinions

Speak with one of our New Patient Coordinators to schedule an appointment, refer a patient or request a second opinion. In urgent cases, we can typically see new patients within 24 hours.

Clinical Trials

Search our wide range of clinical trials, including novel therapies, immunotherapy and personalized therapy.callout bg

Harvard Medical Affiliate

HMS Callout FAD 

As a teaching affiliate of Harvard Medical School, our physicians are passing on their expertise to the next generation of pediatric hematologists and oncologists.